No wonder the SP is were it is!, page-2

First 2 Last

Share
Profile

Follow
WickedAwesome

58 Posts.

23

20/08/22

23:36

Post #: 63230779
Share

Originally posted by redpill: ↑

No wonder GTG's SP is where it is!GTG are just not disclosing to the market - marketing information, are they..
What a wasted opportunity IMO.

Looky here, what I stumbled across doing my research..

MedLab's ASX market ann today, Where's GTGs?

ASX Announcement
Biotech Investor Conference – Emerging Biotech Conquering Global Markets
SYDNEY, August 17, 2022
Medlab Clinical Ltd (ASX:MDC) and Genetic Technologies Ltd (ASX:GTG) are pleased to co-present at the “Biotech
Investor Conference”, held at FB Rice: Patent and Trademark Attorneys in Melbourne 5.00pm on Wednesday 17th August 2022.

The event is proudly sponsored by FB Rice.

About the Event:
Australian biotechnology companies are increasingly offering technology that show promise via the clinical and nonclinical trial path.
This event provides a great opportunity for biotech’s to showcase progression and plans to investors and shareholders.
The conference is designed to allow investors to become more knowledgeable in the role of Biotech work happening in
Australia, and the potential to change global ecosystems by looking at biotech from its core and getting a better
understanding.
A copy of Medlab’s presentation on the day can be found attached.
- ENDS -
Authorisation & Additional information
This announcement was authorised by the Board of Directors of Medlab Clinical Limited.
About Genetic Technologies:
Genetics Technologies Ltd is an established Australian-based molecular diagnostics company, specialising in the
development of integrated genetic risk testing.
Through its revolutionary proprietary technology, GeneType predicts an individual’s risk of developing chronic disease
and enables physicians to proactively manage patient health. For more information, please visit www.genetype.com
About Medlab Clinical:
Medlab Clinical Ltd is an Australian biotechnology company, developing therapeutics using its proprietary delivery
platform NanoCelle®.
Its most advanced program is in cancer pain management with lead drug candidate NanaBis™, a medical cannabis
product for cancer-related bone pain. For more information, please visit www.medlab.co
Medlab – better medicines, better patient care.

.

Expand

Could be that they are constraint? Not wanting to make too much publicity because of other things simmering?

GTG Price at posting: 0.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply